These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15152937)

  • 1. Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
    O'Keeffe J; Kavanagh K
    Anticancer Res; 2004; 24(2A):405-8. PubMed ID: 15152937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J; Doyle S; Kavanagh K
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum repressing efflux pump CDR1 in Candida albicans.
    Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
    BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs.
    Larsen B; Anderson S; Brockman A; Essmann M; Schmidt M
    Yeast; 2006 Aug; 23(11):795-802. PubMed ID: 16921553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G; Turner V; Schulz B; Storch U; Froelich D; Rognon B; Coste AT; Sanglard D; Ruhnke M
    Med Mycol; 2011 Feb; 49(2):132-42. PubMed ID: 20818920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin, an inhibitor of mitoribosomal protein biosynthesis, alters the amphotericin B susceptibility of Candida albicans.
    Geraghty P; Kavanagh K
    J Pharm Pharmacol; 2003 Feb; 55(2):179-84. PubMed ID: 12631409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
    Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
    FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
    Geraghty P; Kavanagh K
    Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.
    Lee RE; Liu TT; Barker KS; Lee RE; Rogers PD
    J Antimicrob Chemother; 2005 May; 55(5):655-62. PubMed ID: 15814599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter.
    Karnani N; Gaur NA; Jha S; Puri N; Krishnamurthy S; Goswami SK; Mukhopadhyay G; Prasad R
    Yeast; 2004 Feb; 21(3):219-39. PubMed ID: 14968428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
    Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
    Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.